🔴 Rua Bioscience is trading 7% down after rights offer left working-capital shortfall

Rua Bioscience is trading at NZD $0.03 (-6.67%) amid a rights-offer funding shortfall.

• The offer raised approximately NZ$1.0 million against NZ$2.8 million sought, and the company said proceeds do not fully meet its working-capital requirements.
• Rua Bioscience is pursuing additional funding options; new shares are expected to be issued and begin trading on October 21.
• No separate announcement directly attributed the share-price move to the rights-offer result.